Lumerah Fetal Pulse Oximeter
Intrapartum fetal oxygen monitoring for assessment of fetal well-being during labor
IDE Pilot StudyActive
Key Facts
Indication
Intrapartum fetal oxygen monitoring for assessment of fetal well-being during labor
Phase
IDE Pilot Study
Status
Active
Company
About Raydiant Oximetry
Raydiant Oximetry is pioneering a technological transformation in intrapartum fetal monitoring to address the high rates of maternal and neonatal morbidity and the overuse of cesarean deliveries. Its lead product, Lumerah™, is a noninvasive fetal pulse oximeter that has received FDA Breakthrough Device designation and is progressing through clinical studies, including an IDE Pilot Study. The company is backed by venture capital, strategic grants, and a key partnership with GE HealthCare, positioning it to address a critical unmet need in the $5B+ global fetal monitoring market.
View full company profile